Cited by 46Telomeres, Telomerase, and SenescenceEpigenetics and DNA MethylationMelanoma and MAPK Pathways

Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma

Open access

Integrity signals

Registry

Crossref · 10.1016/j.ccell.2018.03.009

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Genetic interference with senescence-essential factors, especially using inducible systems, underscored that, similar to other biological states, senescence is not necessarily irreversible.

    “Of note, genetic interference with senescence- essential factors, especially using inducible systems, underscored that, similar to other biological states, senescence is not necessarily irreversible 125,126,149 .”

    From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [149]

  • Robust evidence from studies in primary cell cultures supports the view that fully senescent cells might indeed re-acquire proliferative capacity while remaining, to some extent, locked into other features of cellular senescence.

    “Nevertheless, robust evidence from studies in primary cell cultures supports the view that fully senescent cells might indeed re- acquire proliferative capacity while remaining, to some extent, locked into other features of cellular senescence 5,149 .”

    From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [149]

Cited by

Sorted by citations

Authors
Yu, Y., Schleich, K., Yue, B., Ji, S., Lohneis, P., Kemper, K., Silvis, M. R., Qutob, N., van Rooijen, E., Werner-Klein, M., Li, L., Dhawan, D., Meierjohann, S., Reimann, M., Elkahloun, A., Treitschke, S., Dörken, B., Speck, C., Mallette, F. A., Zon, L. I., Holmen, S. L., Peeper, D. S., Samuels, Y., Schmitt, C. A., & Lee, S.
Corresponding author
Schmitt, Clemens A.
Venue
Cancer Cell
Publisher
Elsevier BV
Published
2018-04
Volume
33
Issue
4
Pages
785
ISSN
1535-6108 (ISSN-L)
OpenAlex
W2888416224
Cited by
46
References
0
Citations by year
2026: 3 · 2025: 6 · 2024: 4 · 2023: 4 · 2022: 7 · 2021: 10 · 2020: 8 · 2019: 3 · 2018: 1
FWCI
3.80
Type
journal article
Language
en
Open access
Locations
Cancer Cell (publishedVersion)
Funders
Biotechnology and Biological Sciences Research Council (BB/M003760/1)
Topics
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
Keywords
LSD1, JMJD2C, melanoma, cellular senescence, oncogenic Ras, BRAF, E2F target genes, histone demethylation, tumor growth inhibition, epigenetic therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review